South Africa Pharmaceutical Glass Packaging Market Size & Outlook, 2026-2034
South Africa Pharmaceutical Glass Packaging Market Insights
- According to Packaging Market Insights analysis, the South Africa Pharmaceutical Glass Packaging Market size was USD 21.32 Million in 2025 and is projected to reach USD 43.8 Million by 2034.
- The South Africa market is projected to grow at a CAGR of 8.35% between 2026 and 2034.
- By segment, Vials emerged as the largest By Packaging Type in terms of market size in 2025.
- Syringe is anticipated to remain the most attractive By Packaging Type segment, recording the fastest growth during the forecast period.
Source: PIAnalysis Company Publications, Primary Interviews.
Other Key Findings
- South Africa contributed 0.91% to the global Pharmaceutical Glass Packaging Market size in 2025.
- By 2034, United States is forecasted to remain the largest global market for Pharmaceutical Glass Packaging Market.
- In Middle East and Africa, United Arab Emirates is projected to capture the leading share of market size by 2034.
- Among Middle East and Africa markets, United Arab Emirates is expected to post the fastest growth, reaching USD 212.17 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 21.32 Million |
| Market Size In 2034 | USD 43.8 Million |
| Largest segment | Vials |
| Units | Revenue in USD Million |
| CAGR | 8.35% (2026-2034) |
| Segmnetation Covered | |
| By Packaging Type |
|
| By Drug Type |
|
| By Distribution Channel |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
South Africa Pharmaceutical Glass Packaging Market By Packaging Type 2026-2034 (USD Million)
| By Packaging Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vials | XX.x | XX.x | XX.x | 8.14 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Bottles | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ampoules | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Syringe | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cartridges | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
South Africa Pharmaceutical Glass Packaging Market By Drug Type 2026-2034 (USD Million)
| By Drug Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Generic | XX.x | XX.x | XX.x | 9.91 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Biologic | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Branded | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.
South Africa Pharmaceutical Glass Packaging Market By Distribution Channel 2026-2034 (USD Million)
| By Distribution Channel | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacies | XX.x | XX.x | XX.x | 7.83 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Hospitals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Wholesalers and Distributors | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: PIAnalysis Company Publications, Primary Interviews.